How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

5,172 results for

Headache in Pregnancy

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

5121. Experimental Headache Induced by Vasoactive Intestinal Polypeptide

Experimental Headache Induced by Vasoactive Intestinal Polypeptide Experimental Headache Induced by Vasoactive Intestinal Polypeptide - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Experimental Headache (...) Induced by Vasoactive Intestinal Polypeptide The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00255320 Recruitment Status : Completed First Posted : November 18, 2005 Last Update Posted : December 9, 2005 Sponsor: Danish Headache Center Information provided by: Danish Headache Center Study Details Study

2005 Clinical Trials

5122. Gonyautoxin in the Treatment of Chronic Tension-Type Headache

Hospital Neurology Clinic over 2 years with duration of symptoms over 3 years Exclusion Criteria: Pregnancy Use of headache prophylactic treatment a month prior to infiltration Myasthenic syndromes Muscular dystrophies Inflammatory myopathies Acute and chronic polineuropathies Use of psychotropic substances 24-hour before infiltration Anticoagulant treatment terminal illnesses (AIDS, cancer) drugs or alcohol abuse Contacts and Locations Go to Information from the National Library of Medicine To learn (...) Gonyautoxin in the Treatment of Chronic Tension-Type Headache Gonyautoxin in the Treatment of Chronic Tension-Type Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Gonyautoxin in the Treatment

2006 Clinical Trials

5123. Intravenous Metoclopramide for the Treatment of Post Concussive Headache: a Randomized Placebo Controlled Trial

hours Immediate and transient post traumatic impairment of neurological functions such as alteration of consciousness, amnesia, disorientation, or disturbance of vision or equilibrium. Onset of headache within one hour of trauma. Significant intra-cranial injury excluded by CT scan or clinical assessment. Exclusion criteria will include age less than or equal to 16 years, known or suspected pregnancy, known hypersensitivity or intolerance to metoclopramide, inability to give informed consent, known (...) of headache within one hour of trauma. Exclusion Criteria: Patients with any of the following exclusion criteria will not be enrolled: Age less than or equal to 19 years. Known or suspected pregnancy. Known hypersensitivity or intolerance to metoclopramide. Inability to give informed consent. Known gastrointestinal hemorrhage, perforation or obstruction. Known seizure disorder. Known pheochromocytoma. Concurrent significant CNS depression due to drugs or alcohol. Concurrent treatment for psychiatric

2005 Clinical Trials

5124. Propofol Injection for Daily Headache

Propofol Injection for Daily Headache Propofol Injection for Daily Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Propofol Injection for Daily Headache The safety and scientific validity (...) subanesthetic dose of propofol will result in improved pain and quality of life for the next 30 days in persons with chronic daily headache (CDH) Specific objectives To measure the effect of a single infusion of propofol at 40 mcg / kg / minute over 60 mins on headache-related quality of life (measured by the Headache Disability Index) and on headache severity (measured by the Headache Index) in subjects with chronic daily headache over 30 days45-47 Condition or disease Intervention/treatment Phase Chronic

2005 Clinical Trials

5125. Treatment of Acute Migraine Headache in Children

Inclusion Criteria: Males or Females age 8-18 years Girls 11 years or older must have a negative urine/serum pregnancy test. Diagnosis of pediatric migrainous headache. The criteria for pediatric migraine headache based on the most recent ICHD criteria are listed below. The requirement of 5 attacks (A) will not be required for this study, this making the diagnosis migrainous headache. As described elsewhere in the protocol, this change is required to make the study applicable to ED patients who require (...) treatment before five attacks have occurred. Exclusion Criteria: Evidence that headache is due to a secondary underlying disorder based on history or physical examination. Pregnant or lactating females. Any investigational drug use within 30 days. Known to have a contraindication to metoclopramide or valproic acid such as pregnancy, liver disease, hematologic disease, or metabolic disease. Have used metoclopramide (or other antidopaminergic medications) or valproic acid within two days of presentation

2006 Clinical Trials

5126. Non-Rhinologic Etiologies of Headaches and Facial Pain in Tertiary Care Setting

of visit. Exclusion criteria include evidence of chronic rhinosinusitis, a modified LM score greater than 2, pregnancy, history of prior facial trauma or tumor in the head and neck region, specifically the nasal area, past history of autoimmune disorder affecting the head and neck region (e.g., Wegener's granulomatosis). Allocation to Groups None Procedures: Participants will be asked to complete a headache questionnaire and the SNOT-20 questionnaire (a validated tool developed by Dr. Picirillo (...) Criteria: patients greater than 18 years of age literate in the English language referred by a physician for primary complaint of "sinusitis" major symptomatic complaint of headache or facial pain/pressure CT scan must have been performed prior and available for review at the time of visit Exclusion Criteria: evidence of chronic rhinosinusitis a modified Lund Mackay score greater than 2 on CT pregnancy history of prior facial trauma or tumor in the head and neck region, specifically the nasal area past

2006 Clinical Trials

5127. Effects of Pretreatment With Ibuprofen in Post-Electroconvulsive Therapy (ECT) Headache

Effects of Pretreatment With Ibuprofen in Post-Electroconvulsive Therapy (ECT) Headache Effects of Pretreatment With Ibuprofen in Post-Electroconvulsive Therapy (ECT) Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies (...) before adding more. Effects of Pretreatment With Ibuprofen in Post-Electroconvulsive Therapy (ECT) Headache The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00258791 Recruitment Status : Withdrawn (first postponed then cancelled as national drug authority changed requirements) First Posted : November

2005 Clinical Trials

5128. Cortical Reorganisation in Patients With Primary Headache Disorders

or psychiatric diseases including depression overuse of analgesics regular intake of opiates or benzodiazepines intake of prophylactic headache medication pregnancy Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor. Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00263991 Locations Layout table for location (...) Cortical Reorganisation in Patients With Primary Headache Disorders Cortical Reorganisation in Patients With Primary Headache Disorders - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Cortical

2005 Clinical Trials

5129. Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache

to 65 Years (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: Yes Criteria Inclusion Criteria: Migraine Headache Exclusion Criteria: Pregnancy and lactation, Pre-medication within six hours of being enrolled in the study, More than six prior headaches per month, Allergy to the study drugs, Non-migraine headache, Substance abuse, Alcohol abuse, Diabetes mellitus, or a coexisting condition that might expose the patients to a disproportionately increased risk (...) Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies

2006 Clinical Trials

5130. Hemodynamic and Headache-Inducing Effect of Intravenous Vasoactive Intestinal Peptide in Migraineurs

Hemodynamic and Headache-Inducing Effect of Intravenous Vasoactive Intestinal Peptide in Migraineurs Hemodynamic and Headache-Inducing Effect of Intravenous Vasoactive Intestinal Peptide in Migraineurs - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. Hemodynamic and Headache-Inducing Effect of Intravenous Vasoactive Intestinal Peptide in Migraineurs The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00272896 Recruitment Status : Completed First Posted : January 9, 2006 Last Update Posted : January 9

2006 Clinical Trials

5131. Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache

months). •Subjects must experience a menstrually-associated migraine during the baseline month, as defined above. •Subjects must be able to accurately predict onset on menses (within 2 days). This will be confirmed during the baseline month. •Subjects who have been on stable headache preventive medications for the 3 months prior to screening. •Subject has negative urine pregnancy test prior to study entry, and is using or agrees to use for the duration of participation a medically acceptable form (...) Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached

2005 Clinical Trials

5132. An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER for the Treatment of Cluster Headaches.

An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER for the Treatment of Cluster Headaches. An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER for the Treatment of Cluster Headaches. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum (...) number of saved studies (100). Please remove one or more studies before adding more. An Open Label Study Using Consecutive Intravenous Depacon With Oral Depakote ER for the Treatment of Cluster Headaches. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00203242 Recruitment Status : Completed First

2005 Clinical Trials

5133. A Clinical Study Examining the Safety and Effectiveness of a New Medication (Keppra®) for the Prevention of Migraine Headaches

attacks from other headache types, if applicable Patient is not currently and has not in the 4 weeks preceding screening received prophylactic treatment for the indication of migraine Patients daily medications have remained at a stable dose for the 4 weeks preceding screening Patient is using or agrees to use for the duration of participation a medically acceptable form of contraception (as determined by investigator), if female of child-bearing potential Patient has negative urine pregnancy test (...) A Clinical Study Examining the Safety and Effectiveness of a New Medication (Keppra®) for the Prevention of Migraine Headaches A Clinical Study Examining the Safety and Effectiveness of a New Medication (Keppra®) for the Prevention of Migraine Headaches - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached

2005 Clinical Trials

5134. A Double-Blind, Placebo-Controlled Study Examining the Use of Topiramate in the Treatment of Cluster Headache

cluster headaches. Subject is using or agrees to use for the duration of participation a medically acceptable form of contraception (as determined by investigator), if female of child-bearing potential Subject has negative urine pregnancy test prior to study entry, if female of child-bearing potential Subject is able to understand and comply with all study requirements Subject provides written informed consent prior to any screening procedures being conducted Exclusion Criteria: Women who are pregnant (...) A Double-Blind, Placebo-Controlled Study Examining the Use of Topiramate in the Treatment of Cluster Headache A Double-Blind, Placebo-Controlled Study Examining the Use of Topiramate in the Treatment of Cluster Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies

2005 Clinical Trials

5135. Atkins Diet for Difficult-to-Control Headaches in Teenagers

Minimum 15 headaches/month for at least 3 months Tried 2 preventative medications previously Exclusion Criteria: Prior use of the Atkins diet for more than 1 week Pregnancy Significant heart or kidney disease Dangerously underweight Using acute pain medications more than 11 days in the past month Medications being changed Contacts and Locations Go to Information from the National Library of Medicine To learn more about this study, you or your doctor may contact the study research staff using (...) Atkins Diet for Difficult-to-Control Headaches in Teenagers Atkins Diet for Difficult-to-Control Headaches in Teenagers - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Atkins Diet for Difficult-to-Control

2005 Clinical Trials

5136. Prophylactic Treatment of Episodic Cluster Headache

episode lasting one month or more. At the time of inclusion, the cluster headache period shall not have lasted more than 3 weeks Exclusion Criteria: Pregnancy, nursing, decreased hepatic og renal function, psychiatric illness, cardiac problems, hypersensitivity to candesartan, previous serious allergic reaction to medication, chronic cluster headache, drug/alcohol abuse, use of antipsychotic,antidepressants, lithium or other prophylactic treatment less than one month prior to inclusion, systolic blood (...) Prophylactic Treatment of Episodic Cluster Headache Prophylactic Treatment of Episodic Cluster Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Prophylactic Treatment of Episodic Cluster Headache

2005 Clinical Trials

5137. Evaluation of Efficacity and Safety of Deep Brain Stimulation (DBS) in Chronic and Treatment-Resistant Cluster Headache(CH)

Years (Adult, Older Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Criteria Inclusion Criteria: between 18 and 65 year old suffering from cluster headache since 3 years at least not responding to others treatments such as : verapamil, lithium or both of them Exclusion Criteria: patient with addiction pregnancy or feeding women contraindication to general anesthetic contraindication to MRI Contacts and Locations Go to Information from the National Library of Medicine To learn (...) Evaluation of Efficacity and Safety of Deep Brain Stimulation (DBS) in Chronic and Treatment-Resistant Cluster Headache(CH) Evaluation of Efficacity and Safety of Deep Brain Stimulation (DBS) in Chronic and Treatment-Resistant Cluster Headache(CH) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached

2008 Clinical Trials

5138. Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache

Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache (TEMPUS) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00534560 Recruitment Status : Completed First Posted : September 26, 2007 Last Update

2007 Clinical Trials

5139. An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache

An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT00531895 Recruitment Status : Completed First Posted : September 19, 2007 Last Update Posted : September 19, 2007 Sponsor: Kraepelin Psiquiatria Clinica Collaborator: Eli Lilly

2007 Clinical Trials

5140. Staccato® Loxapine for Inhalation in Patients With Migraine Headache

Staccato® Loxapine for Inhalation in Patients With Migraine Headache Staccato Loxapine in Migraine (in Clinic) - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Staccato Loxapine in Migraine (in Clinic (...) Details Study Description Go to Brief Summary: The objective of this trial is to assess the efficacy and safety of Staccato Loxapine in patients with migraine headache with or without aura in a clinical setting. Condition or disease Intervention/treatment Phase Migraine Drug: Staccato Loxapine Drug: Staccato Placebo Phase 2 Detailed Description: This study will enroll male and female patients with migraine headache with or without aura. The study will randomize ~160 patients, 1:1:1:1 to receive one

2007 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>